Growth Forecast of the Global DPP4 Inhibitors Market
Despite emergence of novel antidiabetic drug classes including SGLT2 inhibitors and GLP-1 receptor agonists, DPP4 inhibitors maintain algorithmic relevance given favorable safety-tolerability profiles, oral bioavailability, and established efficacy credentials
